NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliat... ( NEW YORK July 15 /- NeoStem Inc...)

HOME >> BIOLOGY >> TECHNOLOGY

NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China

Date:7/15/2009

NEW YORK, July 15 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, was featured on CBS2 News, New York City's local CBS station, on Monday evening July 13 and Tuesday morning July 14, 2009.

The segment "Go! New York" focused on the work of Dr. Christopher Centeno, a NeoStem consultant in stem cell therapies for orthopedics, and featured the success of his innovative process that rapidly grows a patient's own adult stem cells to treat a variety of musculoskeletal diseases. Interviews with Dr. Centeno at the Centeno-Schultz Clinic near Denver, Colorado, and Dr. Robin Smith, CEO of NeoStem, were included.

Dr. Max Gomez, CBS2's medical expert, stated that autologous adult stem cells "have become the cutting edge way to treat osteoarthritis of the knee, hip, and ankle and even back pain." He noted, "The promise appears to be so great that more than 1,000 clinical trials are testing stem cell therapies" for various conditions and "showing promising results for heart failure, diabetes, lupus and even macular degeneration." He added, "That's why a company called NeoStem has begun banking people's own adult stem cells -- now, before you need them."

To see the video of the segment, please go to: http://wcbstv.com/video/?id=130168@wcbs.dayport.com

NeoStem holds an exclusive royalty-bearing, perpetual and irrevocable license to use this technology of Dr. Centeno and Regenerative Sciences, Inc. in the People's Republic o
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State
2. NeoStem Featured in Business Week; Promising Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article
3. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
4. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
5. NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases
6. NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
7. NeoStem, Inc. Announces Agreement With Progenitor Cell Therapy, LLC
8. NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStems VSEL Technology and Advancement of Medical Tourism Initiatives
9. NeoStem Expands Stem Cell Collection Center Network Into New Jersey Led by Leading Plastic Surgeon and Anti-Aging Authority
10. NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
11. NeoStem Receives Notice of Noncompliance from NYSE Alternext US

Post Your Comments:

(Date:11/25/2009)...BOSTON,Nov.25/PRNewswire/--BiotechfirmReplikinsLtd...918pandemicthroughtheprediction,outbreak,andprogre...chemicalanalysisofthevirus.Thenewdatashowsthatthel...speakof3.7(s.d.4.5)duringthevirus,scurrentoutbreak...ekof2.0(s.d.0.1).TheH1N1virus,infectivitycount,how...

(Date:11/25/2009)...NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannoun...alogue: ,, BrazilBioethanolMarketAnalysisandFo...p0165503/Brazil-Bioethanol-Market-Analysis-and-For...nalysisandForecaststo2013 ,, Summary ,, Th...obalbioethanolmarketandtheBrazilbioethanolmarketin...

(Date:11/24/2009)... The New York investment bank KTA...NEU) has agreed an AU$6.7 mil convertible note pri... The private placement was arranged by KTA Capital.... , New York (PRWEB) Nove...nt bank KTA Capital, LLC ("KTA Capital")...

(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...

[0] Biological H1N1 Vaccines: Too Little, Too Late [0] Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 [0] KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals [0] The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close

..., MORRISVILLE, N.C., May 20 Asymchem Laboratories...urer of APIs, intermediates and Drug Products to t... and China, is pleased to announce the recent awar... Award. , , The award was presented at Pfizer,s ... The award was the first in an annual series to be...

...n Surgeries , , ANDOVER, Mass., May 20 Smith &am...sion today announced the launch of the BICEPTOR Te... to the biceps tendon in the shoulder. , , Smith...m is the first that enables surgeons to re-attach ...e, using an all-arthroscopic technique. Other bice...

...r, Inc. (NYSE: BEC ), a leading developer, manuf...tomate and innovate complex biomedical testing, to...shares of its common stock, the proceeds of which ...y announced acquisition of the diagnostic systems ...ness, or the acquisition. Morgan Stanley & Co...

Other Biology Technology:Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem 2 Smith & Nephew Endoscopy Launches the BICEPTOR(TM) Tenodesis System, the First All-Arthroscopic Procedure for Biceps Tendon Repair 2 Smith & Nephew Endoscopy Launches the BICEPTOR(TM) Tenodesis System, the First All-Arthroscopic Procedure for Biceps Tendon Repair 3 Beckman Coulter, Inc. Announces Pricing of Common Stock Offering 2 Beckman Coulter, Inc. Announces Pricing of Common Stock Offering 3

Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem Smith & Nephew Endoscopy Launches the BICEPTOR(TM) Tenodesis System, the First All-Arthroscopic Procedure for Biceps Tendon Repair Beckman Coulter, Inc. Announces Pricing of Common Stock Offering

(Date:11/26/2009)...r 2009 What are the bare essentials of life, the ...ll that can survive on its own? Can we describe th...an entire organism functions as a system? These ar...partnership between the European Molecular Biology... Centre de Regulacio Genmica (CRG) in Barcelona, S...

(Date:11/25/2009)...d in the stomach, may be used to boost resistance ...e, Yale School of Medicine researchers report in a... of Neuroscience . , Parkinson,s disease is caus...a of the midbrain known as the substantia nigra, w...ced production of dopamine in late-stage Parkinson...

(Date:11/25/2009)...of the Cell Death Research Laboratory in the Unive...warded the prestigious Johnson & Johnson Focused F...of brain cell damage in Parkinson,s disease. The a...support of innovation and excellence in science, w...lier this month at an event at the Hyatt Regency H...

[0] First-ever blueprint of a minimal cell is more complex than expected [2] Hormone ghrelin can boost resistance to Parkinson's disease [0] Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's

...fly? The fly,s secret in avoiding death in this wa...out of the way. "This kind of low-power decision-m...omously navigating robots", according to Gwyneth C... will be presenting her work on triggered escape r...nual Main Meeting in Barcelona, on Wednesday 13th ...

...e creation of reading matter, a "nano-printing" te...duction of nano-devices currently built one at a t...vation is the DNA microarray, a nano-device used t...s Alzheimer,s, viral illnesses such as AIDS, and c...uce these complex devices would make DNA analysis ...

...dard for treating newborns suffering from opiate w...ates themselves are superior to sedatives for trea...adone while pregnant. , Opiates appear to better "...potentially reduce the likelihood of seizures," ac...d Osborn, a neonatologist at the Royal Prince Alfr...

Other Biology News:New technique may speed DNA analysis 2 Opiates Better Than Sedatives For Treating Newborns In Withdrawal 2

Taking a flying jump New technique may speed DNA analysis Opiates Better Than Sedatives For Treating Newborns In Withdrawal

Customized Competent E. coli. from Molecular Cloning Laboratories (MCLAB)

Fluorescent Standards Red Standard from Invitrogen

X-Gal from GE Healthcare, formerly Amersham Biosciences

Mouse Anti-Oligodendrocyte Marker O1 Monoclonal Antibody, Unconjugated, Clone O1 from R&D Systems

Biology Products:

Customized Competent E. coli. from Molecular Cloning Laboratories (MCLAB)Fluorescent Standards Red Standard from Invitrogen X-Gal from GE Healthcare, formerly Amersham Biosciences Mouse Anti-Oligodendrocyte Marker O1 Monoclonal Antibody, Unconjugated, Clone O1 from R&D Systems

NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliat...( NEW YORK July 15 /- NeoStem Inc...)